327 (Ticlopidine 250 mg)
Pill imprint 327 has been identified as Ticlopidine hydrochloride 250 mg.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Ticlopidine hydrochloride
- Imprint:
- 327
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 57664-0327
- Inactive Ingredients:
- microcrystalline cellulose
magnesium silicate
pregelatinized corn starch
polyethylene glycol
hypromelloses
titanium dioxide
polysorbate 80
polyethylene glycol 400
More about ticlopidine
Consumer resources
- Other brands: Ticlid
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
